RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis

Código QR

RIPK1 is a negative mediator in Aquaporin 1-driven triple-negative breast carcinoma progression and metastasis

Abstract The triple-negative breast carcinoma (TNBC) is the most aggressive subtype of breast cancer. In TNBC, Aquaporin 1 (AQP1), a water-transporting transmembrane protein, is aberrantly enriched in cytoplasm and causes tumor cell death evasion. However, the carcinogenetic bioactivities of cytopla...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhuming Yin, Wenlin Chen, Jian Yin, Jingyan Sun, Qianrong Xie, Min Wu, Fanxin Zeng, Huiwen Ren
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/f09adfa3bbe341e7862bef9fb05ee956
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Molecular characteristics and metastasis predictor genes of triple-negative breast cancer: a clinical study of triple-negative breast carcinomas.
por: Wen-Hung Kuo, et al.
Publicado: (2012)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Daxing Liu, et al.
Publicado: (2018)

TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
por: Oihana Iriondo, et al.
Publicado: (2018)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Anna E. M. Bastiaansen, et al.
Publicado: (2020)

High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer
por: Gloria V. Echeverria, et al.
Publicado: (2018)

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
por: Cook MT, et al.
Publicado: (2016)

NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation
por: Kai Miao, et al.
Publicado: (2020)

Co-dependency for MET and FGFR1 in basal triple-negative breast cancers
por: Vanessa Y. C. Sung, et al.
Publicado: (2021)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer
por: Qin Wu, et al.
Publicado: (2020)

Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis
por: Renxu Chang, et al.
Publicado: (2018)

Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition
por: Elizabeth Garcia, et al.
Publicado: (2021)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner J, et al.
Publicado: (2015)

Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
por: Dominik Glodzik, et al.
Publicado: (2020)

TTK/hMPS1 is an attractive therapeutic target for triple-negative breast cancer.
por: Virginie Maire, et al.
Publicado: (2013)

A triple negative breast cancer: what it is not!
por: Katakkar SB
Publicado: (2012)

Triple negative breast cancer: an Indian perspective
por: Akhtar M, et al.
Publicado: (2015)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Paolo Peterlongo, et al.
Publicado: (2021)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Nataliia Petruk, et al.
Publicado: (2021)

NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer
por: Ge Qin, et al.
Publicado: (2020)

Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone
por: Qun Lin, et al.
Publicado: (2021)

Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
por: Al-saraireh YM, et al.
Publicado: (2021)

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
por: Haxho F, et al.
Publicado: (2014)

Ubiquitination of RIPK1 suppresses programmed cell death by regulating RIPK1 kinase activation during embryogenesis
por: Xixi Zhang, et al.
Publicado: (2019)

BRCA2 mutations and triple-negative breast cancer.
por: Peter Meyer, et al.
Publicado: (2012)

Triple-negative breast cancer: treatment challenges and solutions
por: Collignon J, et al.
Publicado: (2016)

Opportunities for metastatic triple negative breast cancer therapy
por: Inna P. Ganshina, et al.
Publicado: (2021)

Antiangiogenic therapy for breast cancer with triple negative phenotype
por: Inna P. Ganshina, et al.
Publicado: (2021)

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer.
por: Katsuhiro Yoshikawa, et al.
Publicado: (2021)

TRADD regulates perinatal development and adulthood survival in mice lacking RIPK1 and RIPK3
por: John P. Dowling, et al.
Publicado: (2019)

OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer
por: Jonas Steenbrugge, et al.
Publicado: (2021)

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
por: Kyoungwha Pang, et al.
Publicado: (2019)

Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis
por: Tieying Dong, et al.
Publicado: (2017)

Viral Suppression of RIPK1-Mediated Signaling
por: Darshika J. Udawatte, et al.
Publicado: (2021)

Increased macroH2A1.1 expression correlates with poor survival of triple-negative breast cancer patients.
por: Anne-Claire Lavigne, et al.
Publicado: (2014)

Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype
por: Marina K. Ibragimova, et al.
Publicado: (2021)

Molecular heterogeneity in adjacent cells in triple-negative breast cancer
por: Huebschman ML, et al.
Publicado: (2015)

Pandemic H1N1 influenza A viruses suppress immunogenic RIPK3-driven dendritic cell death
por: Boris M. Hartmann, et al.
Publicado: (2017)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
por: Miyuki Kitahara, et al.
Publicado: (2021)

Comparison of the tumor immune microenvironment of primary hormone receptor-negative HER2-positive and triple negative breast cancer
por: Hanne Vos, et al.
Publicado: (2021)

Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel–cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines
por: Ye J, et al.
Publicado: (2016)